iCAD, Inc. (ICAD)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about iCAD, Inc. (ICAD)
Go deeper and ask any question about ICAD
Company Performance
Current Price
as of Sep 13, 2024$1.64
P/E Ratio
N/A
Market Cap
$43.53M
Description
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Metrics
Overview
- HQNashua, NH
- SectorHealth Technology
- IndustryMedical Specialties
- TickerICAD
- Price$1.64+7.89%
Trading Information
- Market Cap$43.53M
- Float94.37%
- Average Daily Volume (1m)126,916
- Average Daily Volume (3m)172,275
- EPS-$0.11
Company
- Revenue$18.80M
- Rev Growth (1yr)-14.25%
- Net Income-$1.74M
- Gross Margin82.58%
- EBITDA Margin-35.22%
- EBITDA-$1.77M
- EV$14.38M
- EV/Revenue0.76
- P/EN/A
- P/S2.30
Documents
SEC Filings
Earnings Calls
Factset Street Account
Factset